Related Experiment Videos
Neodymium-YAG laser iridotomy in angle closure glaucoma: preliminary study
The British Journal of Ophthalmology
|April 1, 1987
Summary
Q-switched Nd-YAG laser iridotomy effectively treats angle closure glaucoma, with 90% of eyes achieving patency after one or two sessions. This method shows a lower closure rate than argon laser iridotomy, with manageable short-term complications.
Area of Science:
- Ophthalmology
- Laser Surgery
- Glaucoma Treatment
Background:
- Angle closure glaucoma poses a significant risk to vision.
- Laser iridotomy is a common treatment for angle closure glaucoma.
- Evaluating new laser modalities is crucial for improving patient outcomes.
Purpose of the Study:
- To assess the efficacy of Q-switched Nd-YAG laser iridotomy.
- To determine the immediate complications associated with this procedure.
- To compare the outcomes with existing argon laser iridotomy treatments.
Main Methods:
- Prospective, short-term clinical study.
- 40 eyes with acute or chronic angle closure glaucoma were treated.
- Follow-up ranged from 4 to 10 months.
Main Results:
- 90% of eyes achieved iridotomy patency with one or two Nd-YAG laser sessions.
- Pigment epithelium proliferation caused closure in 10% of eyes, lower than argon laser iridotomy.
- Short-term complications included transient ocular hypertension (42%), bleeding, and corneal edema.
Conclusions:
- Q-switched Nd-YAG laser iridotomy is an effective treatment for angle closure glaucoma.
- The procedure demonstrates a favorable safety profile with low closure rates.
- Further research may confirm long-term efficacy and safety compared to other laser modalities.